Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8586071 | 0.84 | SLC6A2 (0.58) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL8121696 | 0.79 | SLC6A2 (0.58) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL94458 | 0.79 | SLC6A2 (0.58) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL7666090 | 0.79 | SLC6A2 (0.58) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL8635078 | 0.78 | TAAR1 (0.52) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL1572105 | 0.78 | SLC6A2 (0.64) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL347187 | 0.78 | SLC6A2 (0.64) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL8851001 | 0.77 | IDO1 (0.44) | SLC6A2TAAR1CYP1A2SMN1; SMN2TSHR | |
| SCHEMBL10739462 | 0.77 | SLC6A2 (0.56) | SLC6A2TAAR1CYP2D6LMNATRPA1 | |
| SCHEMBL4661772 | 0.76 | SLC6A2 (0.61) | SLC6A2TAAR1CYP2D6LMNATRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1144384-B1 | COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARM INC (US) | 2007-10-31 | — | — | EP | claimed |
| EP-3252120-B1 | ANTIFOULING COMPOSITION, ANTIFOULING SHEET, AND METHOD FOR MANUFACTURING ANTIFOULING SHEET | LINTEC CORP (JP) | 2019-08-21 | — | — | EP | disclosed |
| US-10190022-B2 | Antifouling composition, antifouling sheet, and method for manufacturing antifouling sheet | LINTEC CORPORATION (JP) | 2019-01-29 | — | — | US | disclosed |
| US-20180010011-A1 | ANTIFOULING COMPOSITION, ANTIFOULING SHEET, AND METHOD FOR MANUFACTURING ANTIFOULING SHEET | LINTEC CORPORATION (JP) | 2018-01-11 | — | — | US | disclosed |
| EP-3252120-A1 | ANTIFOULING COMPOSITION, ANTIFOULING SHEET, AND METHOD FOR MANUFACTURING ANTIFOULING SHEET | LINTEC Corporation (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-8766243-B2 | Heterocycle-containing asymmetric aromatic compound, compound for organic thin film transistor, and organic thin film transistor using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8759590-B2 | Indenopyrene compound, organic thin film solar cell material using the same, and organic thin film solar cell | IDEMITSU KOSAN CO., LTD. (JP) | 2014-06-24 | — | — | US | disclosed |
| US-20130180590-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM SOLAR CELL COMPRISING SAID COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2013-07-18 | — | — | US | disclosed |
| EP-2599780-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM PHOTOVOLTAIC CELL COMPRISING SAID COMPOUND | Idemitsu Kosan Co., Ltd. (JP) | 2013-06-05 | — | — | EP | disclosed |
| EP-2530070-A1 | DIBENZOFLUORANTHENE COMPOUND AND ORGANIC THIN-FILM SOLAR CELL USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2012-12-05 | — | — | EP | disclosed |
| WO-1994019339-A1 | PIPERAZINOCARBONYLCARBOSTYRILS AS PERIPHERAL VASODILATORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-09-01 | — | — | WO | disclosed |
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5302621-A | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | SANKYO COMPANY, LIMITED (JP) | 1994-04-12 | — | — | US | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0484094-A2 | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | Sankyo Company Limited (JP) | 1992-05-06 | — | — | EP | disclosed |
| EP-0382185-A2 | Carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4600705-A | Gonadoliberin derivatives containing a β-aspartyl group, a process for the preparation thereof and pharmaceutical preparations containing them | Richter Gedeon Veyteszeti Gyar R.T. (HU) | 1986-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130180590-A1 | PHENANTHROLINE COMPOUND, ELECTRON TRANSPORT MATERIAL OBTAINED FROM SAID COMPOUND, AND ORGANIC THIN-FILM SOLAR CELL COMPRISING SAID COMPOUND | SLC43A1, SLC7A5, SLC9A2 | SLC6A2 226/4885TAAR1 4217/4885CYP2D6 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.